Setterwalls advised Immunovia on the deal. Immunovia AB (publ), listed on Nasdaq Stockholm finalized a rights issue of units. Through the rights issue, Immunovia receives initial...
You must be a Standard 1 Year member to access this content.
Setterwalls advised Guard Therapeutics on the deal. Guard Therapeutics International AB (publ) secured a private placement in the form of a directed share issue of approximately...
You must be a Standard 1 Year member to access this content.
Setterwalls advised EQL Pharma on the deal. EQL Pharma AB finalized the listing of the company’s shares on Nasdaq Stockholm. The trading on Nasdaq Stockholm commenced...
You must be a Standard 1 Year member to access this content.
Setterwalls advised Swin Technologies AB (TrusTrace) on the deal. Swin Technologies AB (TrusTrace) raised USD 24 million in an investment round. The investment round was led by...
You must be a Standard 1 Year member to access this content.
Setterwalls advised Crunchfish AB on the deal. Crunchfish AB successfully concluded a share rights issue, generating approximately SEK 51 million in proceeds before factoring in issue...
You must be a Standard 1 Year member to access this content.
Setterwalls assisted SynAct Pharma AB on the deal. SynAct has carried out a private placement of shares and warrants to an entity managed by Heights Capital...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Iconovo on the deal. conovo AB has carried out a private placement of SEK 55 million through a directed new issue of 1,375,000...
You must be a Standard 1 Year member to access this content.
Setterwalls has assisted SynAct Pharma AB in the transaction. SynAct Pharma AB announced the acquisition of the Swiss-incorporated biotech company TXP Pharma AG. The acquisition encompasses...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Guard Therapeutics on the deal. Guard Therapeutics International AB announced private placement of approximately SEK 120 million. Guard Therapeutics International AB (publ) is a...
You must be a Standard 1 Year member to access this content.
Baker McKenzie acted as legal advisor to the banks. Setterwalls has assisted SynAct Pharma. In connection with the acquisition of TXP, SynAct has also carried out...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised InCoax Networks AB on the deal. InCoax Networks AB announced a rights issue that was subscribed to approximately 120.6 percent, and a subsequent...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Qlife Holding on the deal. Qlife Holding announced a rights issue of units, consisting of shares and warrants. Qlife Holding develops and markets...
You must be a Standard 1 Year member to access this content.
